Information de reference pour ce titreAccession Number: | 00000447-199502000-00039.
|
Author: | Spinnato, Joseph A.; Clark, Ann L.; Pierangeli, Silvia S.; Harris, E. Nigel
|
Title: | Obstetrics: Intravenous Immunoglobulin Therapy for the Antiphospholipid Syndrome in Pregnancy.[Miscellaneous Article]
|
Source: | American Journal of Obstetrics & Gynecology. 172(2):690-694, February 1995.
|
Abstract: | OBJECTIVE: Our purpose was to study the influence of intravenous immunoglobulin on pregnancy outcome.
STUDY DESIGN: Pregnancy outcomes were evaluated in five patients with 17 unsuccessful previous pregnancies. Each patient received 400 mg/kg immunoglobulin for 5 days monthly beginning in the first or early second trimester. Four patients with previous thromboembolic events were treated with concomitant heparin prophylaxis. Four patients received 81 mg of aspirin daily.
RESULTS: Short- and long-term decreases of anticardiolipin immunoglobulin G were noted in three patients. Four patients were delivered of healthy infants at term, one at 32 weeks' gestation with a diagnosis of fetal distress. Neither preeclampsia nor fetal intrauterine growth retardation were observed. The immunoglobulin therapy was not associated with major side effects. Significant placental histologic anomalies were not identified.
CONCLUSIONS: The observations suggest that immunoglobulin therapy may improve pregnancy outcomes beyond that observed with heparin and aspirin. A prospective trial is encouraged. (AM J OBSTET GYNECOL 1995;172:690-4.)
(C) Mosby-Year Book Inc. 1995. All Rights Reserved.
|
References: | 1. Harris EN. Syndrome of the black swan. Br J Rheumatol 1987;26:324-6.
2. Lockshin MD, Qamar T, Druzin ML, Goei S. Antibody to cardiolipin, lupus anticoagulant, and fetal death. J Rheumatol 1987;14:259-62.
3. Harris EN, Chan JK, Asherson RA, Aber VR, Gharavi AE, Hughes GR. Thombosis, recurrent fetal loss, and thrombocytopenia. Arch Intern Med 1986;146:2153-6.
4. Alarcon-Segovia D, Deleze M, Oria CV, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective analysis of 500 consecutive patients. Medicine 1990;68:353-65.
5. Branch WD, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992;80:614-20.
6. Lubbe WF, Liggins GC. Role of lupus anticoagulant and autoimmunity in recurrent pregnancy loss. Semin Reprod Endocrinol 1988;2:181-90.
7. Lubbe WF, Butler WS, Palmer SJ, Liggins GC. Lupus anticoagulant in pregnancy. Br J Obstet Gynaecol 1984;91:357-63.
8. Lubbe WF, Palmer SJ, Butler WS, Liggins GC. Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet 1983;1:1361-3.
9. Cowchock SF, Reece AE, Balaban D, Branch WD, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. AM J OBSTET GYNECOL 1992;166:1318-23.
10. Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. AM J OBSTET GYNECOL 1989;160:439-43.
11. Kaja R, Julkunen H, Ammala P, Palosuo T, Kurki P. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies. Acta Obstet Gynecol Scand 1993;72:63-6.
12. Katz VL, Thorp JM, Watson WJ, Fowler L, Heine PR. Human immunoglobulin therapy of preeclampsia associated with lupus anticoagulant and antiphospholipid antibody. Obstet Gynecol 1990;76:986-7.
13. McVerry BA, Spearing R, Smith A. SLE anticoagulant: transient inhibition by high dose immunoglobulin infusions. Br J Haematol 1985;61:579-80.
14. Parke A, Maier D, Wilson D, Andreoli J, Ballow M. Intravenous gamma-globulin, antiphospholipid antibodies, and pregnancy. Ann Intern Med 1989;110:495-6.
15. Harris EN. Serological detection of antiphospholipid antibodies. Stroke 1992;23:3-6.
16. Harris EN. The second international anti-cardiolipin standardization workshop/the Kingston antiphospholipid antibody study (KAPS) group. Am J Clin Pathol 1990;94:476-84.
17. Triplett DA, Brandt JT, Kaczor D, et al. Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. Am J Clin Pathol 1983;79:678-72.
18. Tan EM, Cohen AS, Fries JL, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
19. Lockshin MD, Druzin ML, Goei S, et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985;313:152-6.
20. Loizou S, Byron MA, Englert HR, Walport MJ, Hughes GRV. Association of quantitative anti-cardiolipin antibody levels with fetal loss. Q J Med 1988;68:525-31.
21. Ishii Y, Nagasawa K, Mayumi T, Niho Y. Clinical importance of persistence of anticardiolipin antibodies in systemic lupus erythematosus. J Rheum Dis 1990;49:387-90.
22. Abramowsky CR, Vegas ME, Swinehart G, Gyves MT. Decidual vasculopathy in the placenta in lupus erythematosus. N Engl J Med 1980;303:668-72.
23. Branch WD, Dudley DJ, Mitchell MD. Immunoglobulin G fractions from patients with antiphospholipid syndrome cause fetal death in balb/c mice: a model for autoimmune fetal loss. AM J OBSTET GYNECOL 1990;163:210-6.
24. Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anticardiolipin antibodies. Proc Natl Acad Sci USA 1991;88:3069-73.
25. Dahlman T. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. AM J OBSTET GYNECOL 1993;168:1265-70.
|
Language: | English.
|
Document Type: | General Obstetrics And Gynecology.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0002-9378
|
NLM Journal Code: | 3ni, 0370476
|
Annotation(s) | |
|
|